Result collected from the FLIPR assay (Figure 7B) confirmed the capability of LP-4 in triggering Ca2+ release, since pretreatment of the calcium chelator BATA/AM abolished the calcium dynamics of our LP-4-treated Bax-Bak double knockout DLD-1 colon cancer cells. Here, BAX is linked to malignant colon neoplasm.